NSF expands testing, innovation capabilities with acquisition of Cambium Analytica
Cambium’s expertise in QA testing, batch release, contract research, and product development complements NSF’s robust certification and auditing programs.
USA – NSF, a leading global public health and safety organization, has announced its acquisition of Cambium Analytica, a forward-thinking analytical testing and development company serving the natural food, beverage, and dietary supplement industries.
The move strengthens NSF’s position as a global leader in food safety, quality assurance, and product innovation.
The dietary supplement and natural food testing sectors are experiencing rapid growth, driven by rising consumer demand for health and wellness products, innovation in food-as-medicine concepts, and evolving regulatory frameworks.
With the integration of Cambium Analytica’s expertise, NSF is now better equipped to meet these expanding market needs and deliver integrated, high-performance solutions at scale.
“By integrating Cambium Analytica’s cutting-edge operations with NSF’s eight decades of leadership in safety and testing, we continue to strengthen our position as the partner of choice for clients across the food and nutrition industries,” said Pedro Sancha, President and CEO of NSF. “Together, we anticipate accelerated growth, expanded capabilities, and the addition of exceptional talent to our team.”
Cambium Analytica’s operations will become part of NSF’s Food and Nutrition Division, the organization’s largest and fastest-growing business segment, led by Sarah Krol, Vice President, Food and Nutrition, NSF.
This strategic alignment ensures NSF remains agile in responding to global market shifts, regulatory complexities, and the increasing digitalization of supply chains.
“Cambium Analytica stands out for its unwavering commitment to agility, innovation, and a deep understanding of the specific needs of natural product brands,” said Krol. “These qualities distinguish them in the marketplace and make them an ideal fit for our food and nutrition service portfolio.”
The acquisition is part of NSF’s broader strategy to expand globally and enhance innovation through targeted investments and partnerships.
NSF plans to work closely with Cambium Analytica’s leadership to ensure a seamless transition and unified service experience for clients across food, beverage, nutrition, wellness, and personal care sectors.
According to Alex Adams, CEO of Cambium Analytica, the collaboration represents “the perfect alignment of Cambium Analytica’s innovative, customer-centric approach with NSF’s long-established excellence in public health and safety.”
He added that together, the companies will “lead the next wave of growth in the rapidly evolving consumer products industry, uniting disruptive agility and deep scientific expertise to create an innovative new testing and inspection ecosystem.”
The acquisition bridges crucial gaps in the natural products value chain.
Cambium’s expertise in QA testing, batch release, contract research, and product development complements NSF’s robust certification and auditing programs, providing clients with end-to-end support from concept to compliance.
Cambium Analytica, now operating as “Cambium Analytica, an NSF company,” will continue its operations from Traverse City, Michigan, maintaining its 69-member team as part of NSF’s growing global network.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
